6-150876138-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015440.5(MTHFD1L):āc.276A>Cā(p.Lys92Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000168 in 1,605,700 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015440.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTHFD1L | NM_015440.5 | c.276A>C | p.Lys92Asn | missense_variant | 2/28 | ENST00000367321.8 | NP_056255.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTHFD1L | ENST00000367321.8 | c.276A>C | p.Lys92Asn | missense_variant | 2/28 | 1 | NM_015440.5 | ENSP00000356290 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000693 AC: 17AN: 245446Hom.: 0 AF XY: 0.0000604 AC XY: 8AN XY: 132556
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1453352Hom.: 1 Cov.: 30 AF XY: 0.0000111 AC XY: 8AN XY: 722070
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 06, 2024 | The c.276A>C (p.K92N) alteration is located in exon 2 (coding exon 2) of the MTHFD1L gene. This alteration results from a A to C substitution at nucleotide position 276, causing the lysine (K) at amino acid position 92 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at